What if your pharmacy could tap into one of today’s fastest-growing cash-pay opportunities—without building a cleanroom or obtaining a compounding license?
In this session of Ahead of the Curve, Heather from DiversifyRx sits down with Neal Watterson of AutoPilotRX to reveal how independent pharmacies can begin offering GLP-1s, peptides, and other high-margin sterile compounds through a compliant central-fill model.
Neal walks through how AutoPilotRX’s technology connects pharmacies with licensed 503A fulfillment partners, making it possible to expand services, generate significant new revenue, and stay compliant—all without the cost and complexity of sterile compounding.
If you’ve been wondering how to participate in the growing demand for GLP-1s and peptides while minimizing operational headaches, this webinar breaks down exactly what’s required and how pharmacies are getting started.
🌐 Schedule a Demo: https://www.autopilotrx.com
Timestamp:
0:00 Introduction
3:12 Pharmacy Profit Matrix and Regulatory Updates
5:47 Neil Watterson’s Introduction and Background
11:07 Cash Pay Medicine and Market Trends
15:23 AutoPilotRX’s Solution for Compounding Growth
20:36 Cost and Benefits of the AutoPilot Program
25:26 Q&A and Closing Remarks
31:04 Final Thoughts and Next Steps
Keywords: Ahead of the Curve, Summer Webinar Series, AutoPilotRx, Neal Watterson